Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 19 - Aug 24
Retatrutide remains in the body for approximately 3040 days after the final dose
Tirzepatide is available under FDA-approved prescription uses, while retatrutide is still investigational
A 2025 network meta-analysis ranked nausea risk as follows: orforglipron (highest, relative risk 4.77), liraglutide (3.09), semaglutide (2.94), tirzepatide (2.89), exenatide (2.66), and cagrilintide (2.29)
If you have any questions about risks and side effects, please read the patient information leaflet and ask your doctor or pharmacist
You can eat after your first shot, but eating lightly for the first 24 to 48 hours reduces nausea risk
US$ 25.29
US$ 22.64
US$ 28.13
US$ 26.27
US$ 25.11
US$ 21.98
US$ 28.77
US$ 21.86
US$ 20.36
US$ 22.89
US$ 29.19
US$ 20.55
US$ 23.05
US$ 21.90
